- Home
- WETH vs CRIS Comparison
WETH vs CRIS Comparison
Compare WETH & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WETH | CRIS |
|---|---|---|
| Founded | 1992 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 14.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | WETH | CRIS |
|---|---|---|
| Price | $1.53 | $1.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 78.1K | ★ 120.9K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.55 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $43,519,385.00 | $11,650,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | $2.45 | ★ N/A |
| Revenue Growth | 6.08 | ★ 13.56 |
| 52 Week Low | $0.76 | $0.96 |
| 52 Week High | $3.68 | $3.87 |
Technical Indicators
Market Signals| Indicator | WETH | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 35.75 |
| Support Level | $1.32 | $0.96 |
| Resistance Level | $1.57 | $1.03 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 75.54 | 18.52 |
Price Performance
Historical ComparisonAbout WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.